Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Executive or director change
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Chief Development Officer acquired 28,500 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 22,500 shares (grant or award)
  14. 4 Grant or award See Remarks acquired 37,500 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 32,500 shares (grant or award)
  16. 4 Grant or award Acting Chief Business Officer acquired 16,500 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 37,500 shares (grant or award)
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 18 of 24 · 471 filings